Amia.ai stands apart from generic AI tools by embedding deep regulatory domain expertise into every solution.
The platform is guided by a network of PhD, PharmD, and MD advisors with decades of hands-on experience in FDA and EMA submissions, CMC documentation, clinical development, and regulatory strategy. This ensures that outputs like MedNova-generated documents are not only fast but also aligned with ICH E3 standards, auditable, and ready for sponsor and agency review.
2Market Outlook
The regulatory documentation market for pharma and biotech is growing rapidly as submission complexity and global harmonization demands increase.
AI automation tools like MedNova are positioned to capture significant share by reducing timelines from months to hours and lowering costs for clinical-stage companies facing VC pressure and regulatory scrutiny. Adoption is accelerating among biotechs and CROs seeking to replace or augment expensive medical writing teams.
3Product Overview
MedNova.ai is Amia's flagship AI workbench automating regulatory compliance and document generation for pharma and biotech teams.
It provides autonomous AI workflows that deliver significant savings in time and costs while ensuring FDA-ready outputs for submissions and intelligence.